Johns Hopkins study finds no link between GLP-1 use and neovascular AMD

The wire

1. 01Researchers analyzed records from December 2017 to December 2024 across 12 OHDSI network databases and found GLP-1 receptor agonists did not statistically change neovascular age-related macular degeneration risk in adults with type 2 diabetes.
2. 02Prior literature reported both increased and decreased AMD risk, so the finding gives prescribers a firmer answer when patients raise eye-disease concerns.
3. 03The study is retrospective and code-based, using two case definitions and active-comparator plus self-controlled analyses; it was published online June 2 in Ophthalmology.

From the source

Study Finds No Statistical Link Between Use of Semaglutide and Other GLP-1 Drugs and Risk of Degenerative Eye Disease in Adults with Type 2 Diabetes | Newswise

Digital collage of human hand holding semaglutide injection pen